By continuing to use the site, you agree to our use of cookies and to abide by our Terms and Conditions. We in turn value your personal details in accordance with our Privacy Policy.
Please log in or register. Registered visitors get fewer ads.
Is the protection afforded having been an asymptomatic carrier of the virus equal to, better than or worse than that offered by the vaccine in terms of efficacy and longevity or is it not known?
[Post edited 10 Jan 2021 12:34]
"They break our legs and tell us to be grateful when they offer us crutches."
The Oxford vaccine Director said on R4 this morning that generally the antibody response is related to the how bad the symptoms experienced by the individual are. So someone who suffers badly will generally generate a larger immune response. Logically I’d therefore think those without symptoms would generate little in the way of antibody response.
1
Vaccihe question... on 12:29 - Jan 10 with 286 views
Vaccihe question... on 11:11 - Jan 10 by longtimefan
The Oxford vaccine Director said on R4 this morning that generally the antibody response is related to the how bad the symptoms experienced by the individual are. So someone who suffers badly will generally generate a larger immune response. Logically I’d therefore think those without symptoms would generate little in the way of antibody response.
Interesting...thanks.
"They break our legs and tell us to be grateful when they offer us crutches."